Jason Kelly

Dr. Jason Kelly is the co-founder and CEO of Ginkgo Bioworks.  He took the company public and raised $1.6B in 2021.  Ginkgo has built a 1000+ person, 300,000 sqft automated facility that is available as a service similar to cloud computing but for generating data for generating lab data.  Customers use this facility for AI data generation, RNA drug discovery, enzyme engineering, AAV manufacturing optimization, agricultural biotechnology, and more.  Prior to Ginkgo, Jason received B.S. degrees in Chemical Engineering and Biology and a PhD in Biological Engineering all from MIT.

Agenda sessions